BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 14576954)

  • 21. A catalog of 106 single-nucleotide polymorphisms (SNPs) and 11 other types of variations in genes for transforming growth factor-beta1 (TGF-beta1) and its signaling pathway.
    Watanabe Y; Kinoshita A; Yamada T; Ohta T; Kishino T; Matsumoto N; Ishikawa M; Niikawa N; Yoshiura K
    J Hum Genet; 2002; 47(9):478-83. PubMed ID: 12202987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of functional transforming growth factor (TGF)-beta type II receptor results in insensitivity to TGF-beta1-mediated apoptosis and Epstein-Barr virus reactivation.
    Fukuda M; Kurosaki H; Sairenji T
    J Med Virol; 2006 Nov; 78(11):1456-64. PubMed ID: 16998876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transforming growth factor Beta1 induction of tissue inhibitor of metalloproteinases 3 in articular chondrocytes is mediated by reactive oxygen species.
    Li WQ; Qureshi HY; Liacini A; Dehnade F; Zafarullah M
    Free Radic Biol Med; 2004 Jul; 37(2):196-207. PubMed ID: 15203191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effect of retroviral vector containing anti-sense Smad4 gene on Ito cell line, LI90.
    Xu XB; Leng XS; He ZP; Liang ZQ; Lin K; Wei YH; Yu X; Peng JR
    Chin Med J (Engl); 2004 Aug; 117(8):1170-7. PubMed ID: 15361290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-random allelic losses at 3p, 11p and 13q during HPV-mediated immortalization and concomitant loss of terminal differentiation of human keratinocytes.
    Steenbergen RD; Hermsen MA; Walboomers JM; Meijer GA; Baak JP; Meijer CJ; Snijders PJ
    Int J Cancer; 1998 May; 76(3):412-7. PubMed ID: 9579580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upstream stimulatory factor regulates E box-dependent PAI-1 transcription in human epidermal keratinocytes.
    Allen RR; Qi L; Higgins PJ
    J Cell Physiol; 2005 Apr; 203(1):156-65. PubMed ID: 15372465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smad4 deficiency in cervical carcinoma cells.
    Baldus SE; Schwarz E; Lohrey C; Zapatka M; Landsberg S; Hahn SA; Schmidt D; Dienes HP; Schmiegel WH; Schwarte-Waldhoff I
    Oncogene; 2005 Jan; 24(5):810-9. PubMed ID: 15531914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.
    Kalo E; Buganim Y; Shapira KE; Besserglick H; Goldfinger N; Weisz L; Stambolsky P; Henis YI; Rotter V
    Mol Cell Biol; 2007 Dec; 27(23):8228-42. PubMed ID: 17875924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retinoic acid induces secretion of latent transforming growth factor beta 1 and beta 2 in normal and human papillomavirus type 16-immortalized human keratinocytes.
    Batova A; Danielpour D; Pirisi L; Creek KE
    Cell Growth Differ; 1992 Nov; 3(11):763-72. PubMed ID: 1334692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Smad signal and TGFbeta induced apoptosis in human lymphoma cells.
    Sebestyén A; Barna G; Nagy K; Jánosi J; Paku S; Kohut E; Berczi L; Mihalik R; Kopper L
    Cytokine; 2005 Jun; 30(5):228-35. PubMed ID: 15927846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urokinase expression and binding activity associated with the transforming growth factor beta1-induced migratory and invasive phenotype of mouse epidermal keratinocytes.
    Santibáñez JF; Frontelo P; Iglesias M; Martínez J; Quintanilla M
    J Cell Biochem; 1999 Jul; 74(1):61-73. PubMed ID: 10381262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Smad4 silencing in pancreatic cancer cell lines using stable RNA interference and gene expression profiles induced by transforming growth factor-beta.
    Jazag A; Ijichi H; Kanai F; Imamura T; Guleng B; Ohta M; Imamura J; Tanaka Y; Tateishi K; Ikenoue T; Kawakami T; Arakawa Y; Miyagishi M; Taira K; Kawabe T; Omata M
    Oncogene; 2005 Jan; 24(4):662-71. PubMed ID: 15592526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Functional study on TGF-beta/Smads signaling pathway in human ovarian cancer cells].
    Zhang YY; Li X; Sui LH; Wang Q; Li P; Fu SB
    Yi Chuan Xue Bao; 2004 Aug; 31(8):759-65. PubMed ID: 15481528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in Smad4 expression in human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck squamous cell carcinoma.
    Báez A; Cantor A; Fonseca S; Marcos-Martinez M; Mathews LA; Muro-Cacho CA; Muñoz-Antonia T
    Clin Cancer Res; 2005 May; 11(9):3191-7. PubMed ID: 15867212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Smad expression in human atherosclerotic lesions: evidence for impaired TGF-beta/Smad signaling in smooth muscle cells of fibrofatty lesions.
    Kalinina N; Agrotis A; Antropova Y; Ilyinskaya O; Smirnov V; Tararak E; Bobik A
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1391-6. PubMed ID: 15166010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TGF beta-induced focal complex formation in epithelial cells is mediated by activated ERK and JNK MAP kinases and is independent of Smad4.
    Imamichi Y; Waidmann O; Hein R; Eleftheriou P; Giehl K; Menke A
    Biol Chem; 2005 Mar; 386(3):225-36. PubMed ID: 15843168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transforming growth factor-beta-induced inhibition of myogenesis is mediated through Smad pathway and is modulated by microtubule dynamic stability.
    Zhu S; Goldschmidt-Clermont PJ; Dong C
    Circ Res; 2004 Mar; 94(5):617-25. PubMed ID: 14739161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SPARC regulates TGF-beta1-dependent signaling in primary glomerular mesangial cells.
    Francki A; McClure TD; Brekken RA; Motamed K; Murri C; Wang T; Sage EH
    J Cell Biochem; 2004 Apr; 91(5):915-25. PubMed ID: 15034927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IGF-binding proteins mediate TGF-beta 1-induced apoptosis in bovine mammary epithelial BME-UV1 cells.
    Gajewska M; Motyl T
    Comp Biochem Physiol C Toxicol Pharmacol; 2004 Oct; 139(1-3):65-75. PubMed ID: 15556067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smad2 mediates Erk1/2 activation by TGF-beta1 in suspended, but not in adherent, gastric carcinoma cells.
    Lee MS; Ko SG; Kim HP; Kim YB; Lee SY; Kim SG; Jong HS; Kim TY; Lee JW; Bang YJ
    Int J Oncol; 2004 May; 24(5):1229-34. PubMed ID: 15067346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.